Cargando…
Concomitant Use of Psychotropic Medication With Stimulants for the Treatment of ADHD in Children and Adolescents: A Retrospective Insurance Claims Study in the United States
Objective: To evaluate annual concomitant psychotropic medication use among stimulant-treated children/adolescents with ADHD. Method: Children/adolescents with ≥1 primary ADHD diagnosis who had received ≥30 days of stimulant medication were identified from insurance claims for each calendar year (20...
Autores principales: | Zhou, Zhou, Betts, Keith A., Bocharova, Iryna, Kinrich, David, Spalding, William M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939321/ https://www.ncbi.nlm.nih.gov/pubmed/29991300 http://dx.doi.org/10.1177/1087054718784668 |
Ejemplares similares
-
Concomitant Pharmacotherapy of Psychotropic Medications in EU Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
por: Sikirica, Vanja, et al.
Publicado: (2013) -
Prescription Trends of Psychotropics in Children and Adolescents with Autism Based on Nationwide Health Insurance Data
por: Hong, Minha, et al.
Publicado: (2017) -
Factors Associated With Initiation With Atomoxetine Versus Stimulants in the Treatment of Adults With ADHD: Retrospective Analysis of Administrative Claims Data
por: Van Brunt, David L., et al.
Publicado: (2006) -
Cardiovascular Risk of Concomitant Use of Atypical Antipsychotics and Stimulants Among Commercially Insured Youth in the United States
por: Zhang, Chengchen, et al.
Publicado: (2021) -
Disease burden and direct medical costs of incident adult ADHD: A retrospective longitudinal analysis based on German statutory health insurance claims data
por: Libutzki, Berit, et al.
Publicado: (2020)